Cargando…
Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations
BACKGROUND: Knowledge of what the pharmaceutical industry emphasizes when assessing trial sites during site selection is sparse. A better understanding of this issue can improve the collaboration on clinical trials and increase knowledge of how to attract and retain industry-sponsored trials. Accord...
Autores principales: | Dombernowsky, Tilde, Haedersdal, Merete, Lassen, Ulrik, Thomsen, Simon Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907246/ https://www.ncbi.nlm.nih.gov/pubmed/31829234 http://dx.doi.org/10.1186/s13063-019-3790-9 |
Ejemplares similares
-
Clinical trial allocation in multinational pharmaceutical companies – a qualitative study on influential factors
por: Dombernowsky, Tilde, et al.
Publicado: (2017) -
Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities
por: Dombernowsky, Tilde, et al.
Publicado: (2017) -
Changes in key recruitment performance metrics from 2008–2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov
por: Brøgger-Mikkelsen, Mette, et al.
Publicado: (2022) -
Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal
por: Sotelo, Julio
Publicado: (2006) -
Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors
por: Klopfenstein, Mitchell, et al.
Publicado: (2015)